Cerebral Vasomotor Reactivity in Parkinson's Disease: A Missing Link Between Dysautonomia, White Matter Lesions, and Cognitive Decline?
Overview
Overview
Journal
Mov Disord Clin Pract
Publisher
Wiley
Specialty
Neurology
Date
2020 Nov 9
PMID
33163574
Citations
2
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Peng H, Wu L, Chen Q, Chen S, Wu S, Shi X BMC Public Health. 2024; 24(1):2225.
PMID: 39148063 PMC: 11328353. DOI: 10.1186/s12889-024-19709-x.
Dadar M, Fereshtehnejad S, Zeighami Y, Dagher A, Postuma R, Collins D Mov Disord Clin Pract. 2020; 7(8):996-998.
PMID: 33163575 PMC: 7604642. DOI: 10.1002/mdc3.13073.
References
1.
Zamani B, Mehrabani M, Fereshtehnejad S, Rohani M
. Evaluation of cerebral vasomotor reactivity in Parkinson's disease: is there any association with orthostatic hypotension?. Clin Neurol Neurosurg. 2011; 113(5):368-72.
DOI: 10.1016/j.clineuro.2010.12.014.
View
2.
Krainik A, Maillet A, Fleury V, Sahin M, Tropres I, Lamalle L
. Levodopa does not change cerebral vasoreactivity in Parkinson's disease. Mov Disord. 2012; 28(4):469-75.
DOI: 10.1002/mds.25267.
View
3.
Indelicato E, Fanciulli A, Poewe W, Antonini A, Pontieri F, Wenning G
. Cerebral autoregulation and white matter lesions in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2015; 21(12):1393-7.
DOI: 10.1016/j.parkreldis.2015.10.018.
View
4.
Dadar M, Fereshtehnejad S, Zeighami Y, Dagher A, Postuma R, Collins D
. White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson's Disease. Mov Disord Clin Pract. 2020; 7(6):639-647.
PMC: 7396867.
DOI: 10.1002/mdc3.13003.
View